The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2024 | The biological and psychological uncertainties in precursor disease
Kwee Yong, PhD, FRCP, FRCPath, University College London, London, UK, discusses the biological and psychological uncertainties in precursor disease, focusing on smoldering multiple myeloma (SMM). Prof. Yong highlights the complexities of the genomic and immunological changes in patients, noting the need for dynamic risk models to better predict disease progression. Psychological uncertainty is also significant, as patients are unsure about when or if they will progress to multiple myeloma, along with uncertainties regarding treatment outcomes, toxicities, and access to optimal future care. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
